A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...
The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
Rationale: There is an urgent need for a platform to rapidly evaluate therapies in the outpatient setting, to prevent disease...
